The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Clorox's revenues will expand 2.1% and EPS will increase 1.5%.
The average estimate for revenue is $1.57 billion. On the bottom line, the average EPS estimate is $1.34.
Last quarter, Clorox reported revenue of $1.41 billion. GAAP reported sales were 0.9% higher than the prior-year quarter's $1.40 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.00. GAAP EPS of $0.99 for Q3 were 1.0% lower than the prior-year quarter's $1.00 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 42.1%, 20 basis points worse than the prior-year quarter. Operating margin was 16.5%, 40 basis points better than the prior-year quarter. Net margin was 9.4%, much about the same as the prior-year quarter.
The full year's average estimate for revenue is $5.65 billion. The average EPS estimate is $4.30.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 864 members out of 905 rating the stock outperform, and 41 members rating it underperform. Among 300 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 294 give Clorox a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $80.50.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Clorox. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Clorox to My Watchlist.